Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2017-10-31 Interim / Quarterly Rep…
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2017
2017-10-31 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that the company issued a press release announcing financial results for the three and nine months ended September 30, 2017. The document includes the press release as an exhibit but does not contain detailed financial statements or substantive financial data itself. The length is 3506 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and announces or furnishes a press release with financial results, it should be classified as an Earnings Release (ER). The document is not the full quarterly or interim report but an initial announcement of quarterly financial results. Therefore, the appropriate classification is Earnings Release (ER).
2017-10-30 English
Regulatory Filings 2017
Regulatory Filings
2017-10-24 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a letter from Medpace Holdings, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It references a specific filing (Form S-3) and requests the SEC to declare it effective by a certain date and time. The document is short (1509 characters) and is a formal communication related to a regulatory filing process rather than the filing itself. There is no financial data, report content, or detailed analysis present. This type of document is an announcement or correspondence related to a regulatory filing, not the filing itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2017-10-18 English
Regulatory Filings 2017
Regulatory Filings Classification · 95% confidence The document is a correspondence letter addressed to the SEC Division of Corporation Finance regarding an Amendment No. 2 to a Registration Statement on Form S-3. It discusses responses to SEC staff comments and updates to the Registration Statement. The document is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to securities registration. The length is short (3636 characters) and it is a letter responding to SEC comments, not the registration statement itself. Therefore, it fits best under Regulatory Filings (RNS).
2017-10-04 English
S-3/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-3/A, which is an amendment to a registration statement filed with the SEC under the Securities Act of 1933. It is used for registering securities for public offering, including common stock, preferred stock, debt securities, warrants, and units. The document includes details about the registration fee, offering amounts, and legal disclaimers. It is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to securities registration and offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration information, not just an announcement or a brief notice, so it is not an RPA or RNS filing.
2017-10-04 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.